Affinity Asset Advisors, LLC Infla Rx N.V. Transaction History

Affinity Asset Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.25 - $2.75 $156,250 - $343,750	-125,000 Reduced 38.45%	200,097 $326,000
Q3 2023 Nov 14, 2023	BUY	$2.66 - $4.33 $225,826 - $367,604	84,897 Added 35.34%	325,097 $968,000
Q2 2023 Aug 14, 2023	BUY	$2.05 - $6.1 $492,409 - $1.47 Million	240,200 New	240,200 $1.07 Million

13.2M

5.2K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $67.6M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.